COVID-19 : therapeutic approaches description and discussion

Trindade, Guilherme G.; Caxito, Samyra M. C.; Xavier, Alessandra Rejane E. O.; Xavier, Mauro A. S.; Brandão, Fabiana

Registro completo de metadados

Campo DC	Valor	Idioma
dc.contributor.author	Trindade, Guilherme G.	-
dc.contributor.author	Caxito, Samyra M. C.	-
dc.contributor.author	Xavier, Alessandra Rejane E. O.	-
dc.contributor.author	Xavier, Mauro A. S.	-
dc.contributor.author	Brandão, Fabiana	-
dc.date.accessioned	2021-02-11T13:32:59Z	-
dc.date.available	2021-02-11T13:32:59Z	-
dc.date.issued	2020	-
dc.identifier.citation	TRINDADE, Guilherme G. et al. COVID-19: therapeutic approaches description and discussion. Anais da Academia Brasileira de Ciências, Rio de Janeiro, v. 92, n. 2, e20200466, 2020. DOI: https://doi.org/10.1590/0001-3765202020200466. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652020000300902&lng=en&nrm=iso. Acesso em: 11 fev. 2021. Epub June 12, 2020.	pt_BR
dc.identifier.uri	https://repositorio.unb.br/handle/10482/40060	-
dc.language.iso	Inglês	pt_BR
dc.publisher	Academia Brasileira de Ciências	pt_BR
dc.rights	Acesso Aberto	pt_BR
dc.title	COVID-19 : therapeutic approaches description and discussion	pt_BR
dc.type	Artigo	pt_BR
dc.subject.keyword	Agentes antivirais	pt_BR
dc.subject.keyword	Antiparasitário	pt_BR
dc.subject.keyword	Covid-19	pt_BR
dc.subject.keyword	SARS-CoV-2	pt_BR
dc.subject.keyword	Terapêutica	pt_BR
dc.rights.license	(CC BY)	pt_BR
dc.identifier.doi	https://doi.org/10.1590/0001-3765202020200466	pt_BR
dc.description.abstract1	COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the “Spanish flu” pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date.	pt_BR
dc.identifier.orcid	http://orcid.org/0000-0003-3657-8368	pt_BR
dc.identifier.orcid	http://orcid.org/0000-0002-4266-2964	pt_BR
dc.identifier.orcid	http://orcid.org/0000-0001-8558-4196	pt_BR
dc.identifier.orcid	http://orcid.org/0000-0002-0512-1616	pt_BR
dc.identifier.orcid	http://orcid.org/0000-0001-8358-8062	pt_BR
Aparece nas coleções:	Artigos publicados em periódicos e afins UnB - Covid-19